Phenytoin Correction for Albumin (Sheiner-Tozer)

ورودی‌های بالینی بیمار

حداقل ۰.۵ — حداکثر ۸۰ • واحد: mcg/mL

حداقل ۱ — حداکثر ۶ • واحد: g/dL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
corrected mcg ml
—mcg/mL
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Corrected≥ 0
Direct Clinical Answer

The Phenytoin Correction for Albumin (Sheiner-Tozer) calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include measured mcg ml. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Phenytoin correction for hypoalbuminemia (Sheiner-Tozer): corrected = measured / (0.2 × albumin + 0.1); in renal failure: measured / (0.1 × albumin + 0.1). Albumin in g/dL. Use when albumin <3.5 g/dL to estimate free phenytoin exposure.

Clinical Indication

The Phenytoin Correction for Albumin (Sheiner-Tozer) is indicated for bedside clinical practice to support Phenytoin correction for hypoalbuminemia (Sheiner-Tozer): corrected = measured / (0.2 × albumin + 0.1); in renal failure: measured / (0.1 × albumin + 0.1). Albumin in g/dL. Use when albumin <3.5 g/dL to estimate free phenytoin exposure.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.

Limitations & Contraindications

Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.

Clinical Pearls & Action Plan

Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility.

Formula & Variables:

Corrected = measured / (0.2·albumin + 0.1); renal failure: / (0.1·albumin + 0.1).

Input Parameters

NameTypeRequiredDescription
measured_mcg_mlfloatYesMeasured total phenytoin(mcg/mL)
albumin_g_dlfloatYesSerum albumin(g/dL)
renal_failurestringYesRenal failure (CrCl ≤10 mL/min / ESRD)

Score Interpretation & Guidance

RangeStageDescription
≥ 0CorrectedCorrected phenytoin

Evidence-Based References (EBM)

  • Sheiner LB, Tozer TN. Clinical pharmacokinetics: concepts and applications. (Sheiner-Tozer equation for phenytoin protein binding correction.)

Related calculators